Leap Therapeutics, Inc. (LPTX) NASDAQ

0.40

+0.0437(+12.15%)

Updated at September 30 11:35AM

Currency In USD

Valuation

Market Cap108.15M
Enterprise Value61.16M
P/E Ratio-0.27
PEG Ratio-0.04
Price/Sales Ratio1,760.77
Price/Book Ratio3.08
Enterprise/Revenue-48.33
Enterprise/EBITDA0.01

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-6,568.5
Operating Margin-6,677.8

Management Effectiveness

Return On Assets-3.28
Return On Equity-2.38

Income Statement

Revenue0
Revenue/Share0
Gross Profit-5,000
EBITDA-66.97M
Net Income-67.56M
Diluted EPS-1.81

Balance Sheet

Total Cash18.13M
Total Cash/Share0.44
Total Debt39,000
Total Debt/Equity0.01
Current Ratio1.34
Book Value Per Share0.14

Price History

52-Week Change-83.47
52-Week High4.79
52-Week Low0.22
Moving Average 50 Days0.31
Moving Average 200 Days0.77

Statistics

Average Volume1.14M
Shares Outstanding41.44M
% Held by Institutions33.34

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor1:10
Last Split DateJune 21, 2023